Can Johnson & Johnson's Stelara Become Number 2 Drug In Crohn's Disease Market?

Johnson & Johnson's(NYSE:JNJ) Stelara could become the #2 drug in the Crohn's Disease market over the next few years. Crohn's Disease causes inflammation of the digestive tract. J&J's top selling drugs in this therapeutic area are Remicade and Stelara. AbbVie's Humira is the leader in this market...